Artículo

Pacienza, N.; Pozner, R.G.; Bianco, G.A.; D'Atri, L.P.; Croci, D.O.; Negrotto, S.; Malaver, E.; Gómez, R.M.; Rabinovich, G.A.; Schattner, M. "The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation" (2008) FASEB Journal. 22(4):1113-1123
Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Platelet activation is a critical process during inflammation, thrombosis, and cancer. Here, we show that galectin-1, an endogenous lectin with immunoregulatory properties, plays a key role in human platelet activation and function. Galectin-1 binds to human platelets in a carbohydrate-dependent manner and synergizes with ADP or thrombin to induce platelet aggregation and ATP release. Furthermore, galectin-1 induces F-actin polymerization, up-regulation of P-selectin, and GPIIIa expression; promotes shedding of microvesicles; and triggers conformational changes in GPIIb/IIIa. In addition, exposure to this lectin favors the generation of leukocyte-platelet aggregates. A further mechanistic analysis revealed the involvement of Ca2+ and cyclic nucleotide-dependent pathways in galectin-1-mediated control of platelet activation. Finally, expression of endogenous galectin-1 in human platelets contributes to ADP-induced aggregation. Our study reveals a novel unrecognized role for galectin-1 in the control of platelet physiology with potential implications in thrombosis, inflammation, and metastasis. © FASEB.

Registro:

Documento: Artículo
Título:The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation
Autor:Pacienza, N.; Pozner, R.G.; Bianco, G.A.; D'Atri, L.P.; Croci, D.O.; Negrotto, S.; Malaver, E.; Gómez, R.M.; Rabinovich, G.A.; Schattner, M.
Filiación:Hematological Research Institute, National Academy of Medicine, National Research Council (CONICET), Buenos Aires, Argentina
Laboratory of Immunopathology, Institute of Biology and Experimental Medicine (IBYME), National Research Council (CONICET), Buenos Aires, Argentina
Biochemistry and Molecular Biology Institute, Department of Biological Sciences, National University of La Plata, La Plata, Argentina
Department of Biological Chemistry, Faculty of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina
Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Pacheco de Melo 3081, Buenos Aires (1425), Argentina
Instituto de Biologia Y Medicina Experimental, CONICET, Vuelta de Obligado 2490, Buenos Aires (1428), Argentina
Palabras clave:Hemostasis; Inflammation; Lectin; P-selectin; adenosine diphosphate; adenosine triphosphate; calcium ion; carbohydrate binding protein; cyclic nucleotide; F actin; galectin 1; glycan; glycoprotein IIIa; PADGEM protein; thrombin; article; cell interaction; controlled study; human; human cell; immunoregulation; leukocyte; normal human; polymerization; priority journal; protein binding; protein induction; thrombocyte activation; thrombocyte aggregation; thrombocyte function; thrombocyte release reaction; upregulation; Actins; Adenosine Diphosphate; Binding Sites; Blood Platelets; Flow Cytometry; Galectin 1; Humans; Integrin beta3; Leukocytes; Microscopy, Confocal; P-Selectin; Platelet Activation; Platelet Aggregation; Signal Transduction
Año:2008
Volumen:22
Número:4
Página de inicio:1113
Página de fin:1123
DOI: http://dx.doi.org/10.1096/fj.07-9524com
Título revista:FASEB Journal
Título revista abreviado:FASEB J.
ISSN:08926638
CODEN:FAJOE
CAS:adenosine diphosphate, 20398-34-9, 58-64-0; adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5; calcium ion, 14127-61-8; F actin, 39409-31-9; galectin 1, 258495-34-0; thrombin, 9002-04-4; Actins; Adenosine Diphosphate, 58-64-0; Galectin 1; Integrin beta3; P-Selectin
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08926638_v22_n4_p1113_Pacienza

Referencias:

  • Jurk, K., Kehrel, B.E., Platelets: Physiology and biochemistry (2005) Semin. Thromb. Hemost, 31, pp. 381-392
  • Hartwig, J.H., The platelet: Form and function (2006) Semin. Hematol, 43, pp. S94-S100
  • Croce, K., Libby, P., Intertwining of thrombosis and inflammation in atherosclerosis (2007) Curr. Opin. Hematol, 14, pp. 55-61
  • Marcus, A.J., Safier, L.B., Thromboregulation: Multicellular modulation of platelet reactivity in hemostasis and thrombosis (1993) FASEB J, 7, pp. 516-522
  • Rabinovich, G.A., Baum, L.G., Tinari, N., Paganelli, R., Natoli, C., Liu, F.T., Iacobelli, S., Galectins and their ligands: Amplifiers, silencers or tuners of the inflammatory response (2002) Trends Immunol, 23, pp. 313-320
  • Toscano, M.A., Ilarregui, J.M., Bianco, G.A., Campagna, L., Croci, D.O., Salatino, M., Rabinovich, G.A., Dissecting the pathophysiologic role of endogenous lectins: Glycan-binding proteins with cytokine-like activity (2007) Cytokine Growth Factor Rev, 18, pp. 57-71
  • Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat. Rev. Cancer, 5, pp. 29-41
  • Liu, F.T., Patterson, R.J., Wang, J.L., Intracellular functions of galectins (2002) Biochim. Biophys. Acta, 1572, pp. 263-273
  • Perillo, N.L., Pace, K.E., Seilhamer, J.J., Baum, L.G., Apoptosis of T cells mediated by galectin-1 (1995) Nature, 378, pp. 736-739
  • Rabinovich, G.A., Iglesias, M.M., Modesti, N.M., Castagna, L.F., Wolfenstein-Todel, C., Riera, C.M., Sotomayor, C.E., Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: Biochemical and functional characterization (1998) J. Immunol, 160, pp. 4831-4840
  • Rabinovich, G.A., Ariel, A., Hershkoviz, R., Hirabayashi, J., Kasai, K.I., Lider, O., Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 (1999) Immunology, 97, pp. 100-106
  • Rabinovich, G.A., Ramhorst, R.E., Rubinstein, N., Corigliano, A., Daroqui, M.C., Kier-Joffe, E.B., Fainboim, L., Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms (2002) Cell Death Diff, 9, pp. 661-670
  • Van der Leij, J., van den Berg, A., Harms, G., Eschbach, H., Vos, H., Zwiers, P., van Weeghel, R., Visser, L., Strongly enhanced IL-10 production using stable galectin-1 homodimers (2007) Mol. Immunol, 44, pp. 506-513
  • Vespa, G.N., Lewis, L.A., Kozak, K.R., Moran, M., Nguyen, J.T., Baum, L.G., Miceli, M.C., Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation (1999) J. Immunol, 162, pp. 799-806
  • He, J., Baum, L.G., Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration (2006) Lab. Invest, 86, pp. 578-590
  • La, M., Cao, T. V., Cerchiaro, G., Chilton, K., Hirabayashi, J., Kasai, K., Oliani, S. M. Y. C., and Perretti, M. (2003) A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am. J. Pathol. 163, 1505-1515; Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J.M., Toscano, M.A., Bianco, G.A., Isturiz, M.A., Rabinovich, G.A., A novel function for galectin-1 at the crossroad of innate and adaptive immunity: Galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway (2007) J. Immunol, 178, pp. 436-445
  • Fulcher, J.A., Hashimi, S.T., Levroney, E.L., Pang, M., Gurney, K.B., Baum, L.G., Lee, B., Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix (2006) J. Immunol, 177, pp. 216-226
  • Garin, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollon, E., Wait, R., Lechler, R.I., Galectin-1: A key effector of regulation mediated by CD4+CD25+ T cells (2007) Blood, 109, pp. 2058-2065
  • Rabinovich, G.A., Daly, G., Dreja, H., Tailor, H., Riera, C.M., Hirabayashi, J., Chernajovsky, Y., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J. Exp. Med, 190, pp. 385-398
  • Santucci, L., Fiorucci, S., Rubinstein, N., Mencarelli, A., Palazzetti, B., Federici, B., Rabinovich, G.A., Morelli, A., Galectin-1 suppresses experimental colitis in mice (2003) Gastroenterology, 124, pp. 1381-1394
  • Toscano, M.A., Commodaro, A.G., Ilarregui, J.M., Bianco, G.A., Liberman, A., Serra, H.M., Hirabayashi, J., Rabinovich, G.A., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses (2006) J. Immunol, 176, pp. 6323-6332
  • Perone, M.J., Bertera, S., Tawadrous, Z.S., Shufesky, W.J., Piganelli, J.D., Baum, L.G., Trucco, M., Morelli, A.E., Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice (2006) J. Immunol, 177, pp. 5278-5289
  • Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Zwirner, N.W., Hernandez, J.D., Rabinovich, G.A., Differential glycosylation of Th1, Th2 and Th17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol, 8, pp. 825-834
  • Van den Brule, F.A., Buicu, C., Baldet, M., Sobel, M.E., Cooper, D.N., Marschal, P., Castronovo, V., Galectin-1 modulates human melanoma cell adhesion to laminin (1995) Biochem. Biophys. Res. Commun, 209, pp. 760-767
  • Camby, I., Belot, N., Lefranc, F., Sadeghi, N., de Launoit, Y., Kaltner, H., Musette, S., Kiss, R., Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases (2002) J. Neuropathol. Exp. Neurol, 61, pp. 585-596
  • Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Griffioen, A.W., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc. Natl. Acad. Sci. U. S. A, 103, pp. 15975-15980
  • Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
  • Hirabayashi, J., Hashidate, T., Arata, Y., Nishi, N., Nakamura, T., Hirashima, M., Urashima, T., Kasai, K., Oligosaccharide specificity of galectins: A search by frontal affinity chromatography (2002) Biochim. Biophys. Acta, 1572, pp. 232-254
  • Schattner, M., Lazzari, M., Trevani, A.S., Malchiodi, E., Kempfer, A.C., Isturiz, M.A., Geffner, J.R., Activation of human platelets by immune complexes prepared with cationized human IgG (1993) Blood, 82, pp. 3045-3051
  • Abrams, C.S., Ellison, N., Budzynski, A.Z., Shattil, S.J., Direct detection of activated platelets and platelet-derived microparticles in humans (1990) Blood, 75, pp. 128-138
  • Hu, H., Varon, D., Hjemdahl, P., Savion, N., Schulman, S., Li, N., Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins (2003) Thromb. Haemost, 90, pp. 679-687
  • Shattil, S.J., Hoxie, J.A., Cunningham, M., Brass, L.F., Changes in the platelet membrane glycoprotein IIb IIIa complex during platelet activation (1985) J. Biol. Chem, 260, pp. 11107-11114
  • Heijnen, H.F., Schiel, A.E., Fijnheer, R., Geuze, H.J., Sixma, J.J., Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α-granules (1999) Blood, 94, pp. 3791-3799
  • Biro, E., Akkerman, J.W., Hoek, F.J., Gorter, G., Pronk, L.M., Sturk, A., Nieuwland, R., The phospholipid composition and cholesterol content of platelet-derived microparticles: A comparison with platelet membrane fractions (2005) J. Thromb. Haemost, 3, pp. 2754-2763
  • Schwarz, U.R., Walter, U., Eigenthaler, M., Taming platelets with cyclic nucleotides (2001) Biochem. Pharmacol, 62, pp. 1153-1161
  • McEver, R.P., Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation (2001) Thromb. Haemost, 86, pp. 746-756
  • He, J., Baum, L.G., Presentation of galectin-1 by extracellular matrix triggers T cell death (2004) J. Biol. Chem, 279, pp. 4705-4712
  • Timoshenko, A.V., Gorudko, I.V., Maslakova, O.V., Andre, S., Kuwabara, I., Liu, F.T., Kaltner, H., Gabius, H.J., Analysis of selected blood and immune cell responses to carbohydrate-dependent surface binding of proto- and chimera-type galectins (2003) Mol. Cell. Biochem, 250, pp. 139-149
  • Shattil, S.J., Newman, P.J., Integrins: Dynamic scaffolds for adhesion and signaling in platelets (2004) Blood, 104, pp. 1606-1615
  • Wagner, D.D., New links between inflammation and thrombosis (2005) Arterioscler. Thromb. Vasc. Biol, 25, pp. 1321-1324
  • Afshar-Kharghan, V., Thiagarajan, P., Leukocyte adhesion and thrombosis (2006) Curr. Opin. Hematol, 13, pp. 34-39
  • Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Furie, B., Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin (2003) J. Exp. Med, 197, pp. 1585-1598
  • Merten, M., Thiagarajan, P., P-selectin expression on platelets determines size and stability of platelet aggregates (2000) Circulation, 102, pp. 1931-1936
  • Bode, A.P., Sandberg, H., Dombrose, F.A., Lentz, B.R., Association of factor V activity with membranous vesicles released from human platelets: Requirement for platelet stimulation (1985) Thromb. Res, 39, pp. 49-61
  • Pereira, J., Alfaro, G., Goycoolea, M., Quiroga, T., Ocqueteau, M., Massardo, L., Perez, C., Mezzano, D., Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state (2006) Thromb. Haemost, 95, pp. 94-99
  • Van den Goor, J.M., van den Brink, A., Nieuwland, R., van Oeveren, W., Rutten, P.M., Tepaske, R., Tijssen, J.G., Eijsman, L., Generation of platelet-derived microparticles in patients undergoing cardiac surgery is not affected by complement activation (2003) J. Thorac. Cardiovasc. Surg, 126, pp. 1101-1106
  • Silvestre, M.M., The effects of eprosartan on cytoplasmic free calcium mobilisation, platelet activation and microparticle formation in hypertension. Could they be relevant to stroke prevention (2005) J. Renin Angiotensin Aldosterone Syst, 6 (SUPPL. 1), pp. S1-S3
  • Sims, P.J., Faioni, E.M., Wiedmer, T., Shattil, S.J., Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity (1988) J. Biol. Chem, 263, pp. 18205-18212
  • Merten, M., Pakala, R., Thiagarajan, P., Benedict, C.R., Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism (1999) Circulation, 99, pp. 2577-2582
  • Brill, A., Dashevsky, O., Rivo, J., Gozal, Y., Varon, D., Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization (2005) Cardiovasc. Res, 67, pp. 30-38
  • Stowell, S.R., Karmakar, S., Stowell, C.J., Dias-Baruffi, M., McEver, R.P., Cummings, R.D., Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells (2007) Blood, 109, pp. 219-227
  • Wiedmer, T., Sims, P.J., Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles (1991) Blood, 78, pp. 2880-2886
  • Scott, K., Weinberg, C., Galectin-1: A bifunctional regulator of cellular proliferation (2004) Glycoconj. J, 19, pp. 467-477
  • Camby, I., Le Mercier, M., Lefranc, F., Kiss, R., Galectin-1: A small protein with major functions (2006) Glycobiology, 16, pp. 137R-157R
  • Moiseeva, E.P., Williams, B., Goodall, A.H., Samani, N.J., Galectin-1 interacts with β1 subunit of integrin (2003) Biochem. Biophys. Res. Commun, 310, pp. 1010-1016
  • Gu, M., Wang, W., Song, W.K., Cooper, D.N., Kaufman, S.J., Selective modulation of the interaction of α7β1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation (1994) J. Cell Sci, 107, pp. 175-181
  • De Cicco, M., The prothrombotic state in cancer: Pathogenic mechanisms (2004) Crit. Rev. Oncol. Hematol, 50, pp. 187-196
  • Falanga, A., Marchetti, M., Vignoli, A., Balducci, D., Clotting mechanisms and cancer: Implications in thrombus formation and tumor progression (2003) Clin. Adv. Hematol. Oncol, 1, pp. 673-678
  • Caine, G.J., Stonelake, P.S., Lip, G.Y., Kehoe, S.T., The hypercoagulable state of malignancy: Pathogenesis and current debate (2002) Neoplasia, 4, pp. 465-473
  • Jain, S., Zuka, M., Liu, J., Russell, S., Dent, J., Guerrero, J.A., Forsyth, J., Ware, J., Platelet glycoprotein Ibα supports experimental lung metastasis (2007) Proc. Natl. Acad. Sci. U. S. A, 104, pp. 9024-9028
  • Pearlstein, E., Ambrogio, C., Karpatkin, S., Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice (1984) Cancer Res, 44, pp. 3884-3887
  • Amirkhosravi, A., Mousa, S.A., Amaya, M., Blaydes, S., Desai, H., Meyer, T., Francis, J.L., Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454 (2003) Thromb. Haemost, 90, pp. 549-554
  • Bakewell, S.J., Nestor, P., Prasad, S., Tomasson, M.H., Dowland, N., Mehrotra, M., Scarborough, R., Weilbaecher, K.N., Platelet and osteoclast β3 integrins are critical for bone metastasis (2003) Proc. Natl. Acad. Sci. U. S. A, 100, pp. 14205-14210
  • Geng, J.G., Chen, M., Chou, K.C., P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis (2004) Curr. Med. Chem, 11, pp. 2153-2160
  • Palumbo, J.S., Talmage, K.E., Massari, J.V., La Jeunesse, C.M., Flick, M.J., Kombrinck, K.W., Jirouskova, M., Degen, J.L., Platelets and fibrinogen increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells (2005) Blood, 105, pp. 178-185
  • Saussez, S., Camby, I., Toubeau, G., Kiss, R., Galectins as modulators of tumor progression in head and squamous cell carcinomas (2007) Head Neck, 29, pp. 874-884

Citas:

---------- APA ----------
Pacienza, N., Pozner, R.G., Bianco, G.A., D'Atri, L.P., Croci, D.O., Negrotto, S., Malaver, E.,..., Schattner, M. (2008) . The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB Journal, 22(4), 1113-1123.
http://dx.doi.org/10.1096/fj.07-9524com
---------- CHICAGO ----------
Pacienza, N., Pozner, R.G., Bianco, G.A., D'Atri, L.P., Croci, D.O., Negrotto, S., et al. "The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation" . FASEB Journal 22, no. 4 (2008) : 1113-1123.
http://dx.doi.org/10.1096/fj.07-9524com
---------- MLA ----------
Pacienza, N., Pozner, R.G., Bianco, G.A., D'Atri, L.P., Croci, D.O., Negrotto, S., et al. "The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation" . FASEB Journal, vol. 22, no. 4, 2008, pp. 1113-1123.
http://dx.doi.org/10.1096/fj.07-9524com
---------- VANCOUVER ----------
Pacienza, N., Pozner, R.G., Bianco, G.A., D'Atri, L.P., Croci, D.O., Negrotto, S., et al. The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J. 2008;22(4):1113-1123.
http://dx.doi.org/10.1096/fj.07-9524com